跳到正文
FDA 官方药品与生物制品信息·· 2 天前精选AI 评分65

Greenwich Rx 因潜在无菌保证不足自愿全国召回复方无菌产品

Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Sterile Products Due to Lack of Sterility Assurance

AI 导读

503A 复方药房 Greenwich Rx 于 2026 年 11 月 20 日宣布自愿在全国范围召回仍在有效使用期内的特定批次复方无菌产品,其中包括其为另一家药房 Clove Rx 配制的部分产品,原因是潜在无菌保证不足。

推荐理由

公告给出召回产品范围、全国发放时间窗与批号清单入口,可用于核对复方无菌产品的在售批次。

正文 · 原文

COMPANY ANNOUNCEMENT

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.

Read Announcement

Summary

Company Announcement Date:
November 20, 2026
FDA Publish Date:
November 20, 2026
Product Type:
Drugs
Reason for Announcement:

Recall Reason Description

Potential lack of sterility assurance

Company Name:
Greenwich
Brand Name:

Brand Name(s)

Greenwich Rx

Product Description:

Product Description

Compounded sterile products


Company Announcement

FOR IMMEDIATE RELEASE - Tomball, Texas – November 20, 2026 – Greenwich Rx, a 503A compounding pharmacy, is voluntarily recalling specific lots of compounded sterile products that remain within their beyond-use dates to the consumer level, including some products that were compounded by Greenwich Rx for another pharmacy, Clove Rx. For a complete list of affected products and lots, see the link below. The products are being recalled due to a potential lack of sterility assurance. These concerns arose following an inspection of the pharmacy by the FDA and Greenwich Rx’s evaluation of the affected products.

Risk Statement: Use of a drug product intended to be sterile, that is not sterile, could result in serious infections, which may be life threatening. Greenwich Rx has not identified any evidence of contamination in the recalled products; however, Greenwich Rx is initiating this recall as a precautionary measure, and you should follow all instructions below. To date, Greenwich Rx has not received any reports of adverse events related to this recall.

The affected products were dispensed nationwide between August 10, 2026 and September 21, 2026. A list of affected products, lot numbers, and beyond-use dates (expiration dates) is available at https://greenwichrx.org/news/general-recall-2026-11. Customers of Greenwich Rx and Clove Rx should compare the information on their medication labels with this list of affected products to confirm whether their medication is part of the recall.

Greenwich Rx is notifying its affected customers of this voluntary recall by mail. Customers who received medications through Clove Rx should review the affected product list, even if they have not received a direct recall notification. Greenwich Rx encourages those customers to contact Sedgwick using the information below if they have any questions about whether a product received through Clove Rx is included in the recall.

Consumers and clinics that have a product being recalled should stop use of the product immediately and discard it. Information regarding safe disposal of unused medicines is available at FDA.gov/DrugDisposal.

Customers can direct questions regarding this recall to Sedgwick at 888-243-5547 or GreenwichRx6588@sedgwick.com Monday through Friday between 8:00 AM to 5:00 PM Eastern Time. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using the recalled drug products.

Adverse reactions or quality problems experienced with the use of the products may also be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

来源:FDA 官方药品与生物制品信息 · fda.gov